abstract |
Compounds having a structure of Formula I: or a pharmaceutically acceptable salt or tautomer thereof, wherein Z 1 , Z 2 , Z 3 and Z 4 are as defined herein. Uses of such compounds for treatment of various indications, including prostate cancer as well as methods of treatment involving such compounds are also provided. |